1.70
2.30%
-0.04
Geovax Labs Inc 주식(GOVX)의 최신 뉴스
GeoVax announces $1.3 million direct offering By Investing.com - Investing.com
Investing.com
Earnings call: GeoVax reports progress on key vaccine trials - Investing.com Australia
Investing.com Australia
Earnings call: GeoVax reports progress on key vaccine trials - Investing.com Canada
Investing.com Canada
Earnings call: GeoVax reports progress on key vaccine trials - Investing.com UK
Investing.com UK
GeoVax Announces Collaboration with American Gene Technologies for HIV Functional Cure - Yahoo News UK
Yahoo News UK
GeoVax to Conduct Partnering Meetings During BIO International Convention June 19-22 - Yahoo News UK
Yahoo News UK
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
GlobeNewswire Inc.
GeoVax reports progress on next-gen Covid-19 vaccine - Investing.com India
Investing.com India
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress - Yahoo Finance
Yahoo Finance
GeoVax to Present at the 36th Annual Roth Conference - GlobeNewswire
GlobeNewswire
GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire Inc.
InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
Benzinga
GeoVax to Present at the 2024 BIO CEO & Investor Conference
GlobeNewswire Inc.
GeoVax to Present at the 2024 BIO CEO & Investor Conference - Yahoo Finance
Yahoo Finance
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine ... - GlobeNewswire
GlobeNewswire
GeoVax Labs Announces 1-for-15 Reverse Stock Split - TipRanks.com - TipRanks
TipRanks
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
GlobeNewswire Inc.
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement - GlobeNewswire
GlobeNewswire
GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology
GlobeNewswire Inc.
GeoVax Announces Issuance of Malaria Vaccine Patent
GlobeNewswire Inc.
GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024
GlobeNewswire Inc.
GeoVax Labs And 2 Other Stocks Under $2 Insiders Are Buying
Benzinga
GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox - GlobeNewswire
GlobeNewswire
GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress
GlobeNewswire Inc.
GeoVax to Participate in Upcoming December Investor Events
GlobeNewswire Inc.
GeoVax Presents Positive Phase 2 Trial Data for Next-Generation COVID-19 Vaccine at World Vaccine Congress - Onlymyhealth
Onlymyhealth
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based ... - Yahoo Finance
Yahoo Finance
GeoVax Labs vaccinates first patients in trial of GEO-CM04S1 - Clinical Trials Arena
Clinical Trials Arena
GeoVax initiates trial of new Covid-19 vaccine GEO-CM04S1 - Clinical Trials Arena
Clinical Trials Arena
GeoVax, ABL Partner To Advance CGMP Production Of Vaccine Candidates - Contract Pharma
Contract Pharma
GeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Update - GlobeNewswire
GlobeNewswire
City of Hope-developed COVID-19 vaccine found effective against variants - City of Hope
City of Hope
MULN: 5 Penny Stocks to Sell Before They Hit Zero - StockNews.com
StockNews.com
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq ... - GlobeNewswire
GlobeNewswire
Covid Vaccine Developed by City of Hope Shows Success in Phase 1 Clinical Trial - Los Angeles Business Journal
Los Angeles Business Journal
GeoVax Announces Issuance of Cancer Vaccine Patent - GlobeNewswire
GlobeNewswire
GeoVax vaccine targeting virus in two places shows promise; virus may become resistant to antibody drugs - Reuters
Reuters
GeoVax commences dosing in Covid-19 booster shot trial - Clinical Trials Arena
Clinical Trials Arena
GeoVax Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split - GlobeNewswire
GlobeNewswire
GeoVax Labs, Inc. Announces Approval for Trading on OTCQB Venture Market - GlobeNewswire
GlobeNewswire
GeoVax and Sino Biological establish exclusive supply agreement for research grade bioreagents related to SARS ... - News-Medical.Net
News-Medical.Net
GeoVax Provides Update on Coronavirus (COVID-19) Vaccine Development Program - GlobeNewswire
GlobeNewswire
GeoVax Announces Reverse Stock Split - GlobeNewswire
GlobeNewswire
HIV Vaccine Candidate Launched Phase 1 Study — Precision Vaccinations News - Precision Vaccinations
Precision Vaccinations
GeoVax Reports on Vaccine Development Progress - Yahoo News UK
Yahoo News UK
GeoVax to Discuss Zika Vaccine Development Progress at American Society for Virology Meeting - Yahoo News UK
Yahoo News UK
자본화:
|
볼륨(24시간):